Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10192073

Immunotherapy.

G M Lord
View original source ↗Export metadata ↓

Abstract

A forward looking conference took place at the Royal College of Physicians in June 1998. The audience, which included many scientific and clinical immunologists from both the university and pharmaceutical sector, participated knowledgeably and critically in the discussions on possible future treatments for immunologically caused diseases and on the scientific principles which may bring about further developments in immunotherapy.

Explore related subjects

Autoimmune DiseasesGenetic TherapyHumansImmune ToleranceImmunotherapyT-LymphocytesTransplantation ImmunologyConference Proceedings

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G M Lord. Immunotherapy.. https://pubmed.ncbi.nlm.nih.gov/10192073/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group].

EXPERIMENTAL BASIS AND CLINICAL OBSERVATIONS: Remission of an autoimmune disease has been observed in certain patients after bone marrow allograft from a healthy donor. Autoimmune disease in the donor can also be transmitted to an unaffected recipient. These phenomena would be hematopoietic-dependent. BONE MARROW ALLOGRAFTS: Indications for the treatment of refractory autoimmune diseases are exceptional due to the related mortality even in patients without malignant hematologic disease. A NEW THERAPEUTIC CONCEPT: Therapeutic intensification, followed with autologous peripheral stem cell grafts, a procedure with a mortality below 3% in 1997, constitutes a therapeutic alternative in these difficult indication concerning severe refractory autoimmune diseases including: sclerodermia, vasculitis, lupus, inflammatory myositis, autoimmune cyopenia.

Autoimmune Diseases↗
PubMed1999

No evidence for association of multiple sclerosis with the complement factors C6 and C7.

Four genome screens in multiple sclerosis have been completed and each has identified evidence for linkage in the pericentromeric region of chromosome 5. This region encodes a number of candidate genes including those for the complement components C6, C7 and C9. We have used a multiplexed oligoligation assay (OLA) to test single nucleotide polymorphisms (SNPs) from the C6 and C7 genes for evidence of association with multiple sclerosis in our sibling pair families. There was no statistically significant difference in the allele frequencies of these polymorphisms in the index cases from our families when compared with locally derived controls. No evidence for transmission distortion was seen with any of the polymorphisms, or with the haplotype built from the three SNPs from the C7 gene. Despite offering themselves as potential candidates these complement genes appear not to confer susceptibility to multiple sclerosis.

Autoimmune Diseases↗